DOCSLIB.ORG

European Patent Office Office Europeenpeen Des Brevets EP 0 674 618 B1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
European Patent Office Office Europeenpeen Des Brevets EP 0 674 618 B1 Europaisches Patentamt (19) European Patent Office Office europeenpeen des brevets EP 0 674 618 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) intci.6: C07C 317/32, C07C 233/22, of the grant of the patent: C07C 315/04, C07D 301/19, 09.09.1998 Bulletin 1998/37 C07D 263/14, A61K31/16 (21) Application number: 94903599.2 (86) International application number: PCT/US93/12071 (22) Date of filing: 15.12.1993 (87) International publication number: WO 94/14764 (07.07.1994 Gazette 1994/15) (54) ASYMMETRIC PROCESS FOR PREPARING FLORFENICOL, THIAMPHENICOL, CHLORAMPHENICOL AND OXAZOLINE INTERMEDIATES ASYMMETRISCHES HERSTELLUNGSVERFAHREN FUR FLORFENICOL, THIAMPHENICOL, CHLORAMPHENICOL UND OXAZOLIN-ZWISCHENPRODUKTE PROCEDE ASYMETRIQUE DE PREPARATION DE FLORFENICOL, THIAMPHENICOL, CHLORAMPHENICOL ET D'INTERMEDI AIRES OXAZOLINE (84) Designated Contracting States: (74) Representative: AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT von Kreisler, Alek, Dipl.-Chem. et al SE Patentanwalte, von Kreisler-Selting-Werner, (30) Priority: 18.12.1992 US 993932 Bahnhofsvorplatz 1 (Deichmannhaus) 50667 Koln (DE) (43) Date of publication of application: 04.10.1995 Bulletin 1995/40 (56) References cited: EP-A- 0 423 705 EP-A- 0 472 790 (73) Proprietor: SCHERING CORPORATION WO-A-92/07824 US-A- 4 235 892 Kenilworth New Jersey 07033 (US) US-A- 4 876 352 US-A- 4 900 847 (72) Inventors: • CHEMICAL ABSTRACTS, vol. 107, no. 1, 06 July • WU, Guang-Zhong 1987, Columbus, Ohio, US; abstract no. 6859M, Somerville, NJ 08876 (US) JOMMI, GIANCARLO ET AL '2-Oxazolidinones • TORMOS, Wanda, I. as regioselective protection of beta-amino Elizabeth, NJ 07202 (US) alcohols in the synthesis of 2-amino-1-aryl-3-fluoro-1-propanols' page 632; column 1; & GAZZ. CHIM. ITAL. vol. 116, no. 9, 1986,, pages 485 - 489 DO 00 CO ^> Is- CD Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice the Patent Office of the Notice of shall be filed in o to European opposition to European patent granted. opposition a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. a. 99(1) European Patent Convention). LU Printed by Jouve, 75001 PARIS (FR) EP0 674 618 B1 Description The present invention relates to a stereospecific process for preparing florfenicol, thiamphenicol and chloramphen- icol having the correct relative and absolute stereochemistry from achiral starting materials. The present invention also 5 relates to a process for isomerizing the S,S-enantiomer of florfenicol to florfenicol having the proper R,S stereochem- istry. In addition, the present invention relates to a stereospecific process for preparing oxazoline intermediates useful in the synthesis of florfenicol, thiamphenicol, chloramphenicol, and related antibiotics. BACKGROUND OF THE INVENTION 10 Florfenicol (I) is a broad spectrum antibiotic having activity against Gram positive, Gram negative and thiamphen- icol-resistant bacteria, as disclosed in U.S. Patent No. 4,235,892. OH 40 I ^ o2n- ny o Several approaches to the synthesis of florfenicol have been reported, e.g. Tyson, Chem Ind., (1 988) pp. 1 1 8-1 22; so and U.S. 4,743,700. However, these processes typically suffer from low overall yields and require either a resolution step or expensive chiral starting materials. Schumacher et al., J. Org. Chem., 55, 18 (1990) pp. 5291-5294, describes a synthesis of florfenicol starting from a commercially available chiral starting material, e.g. compound (1). Compound (1) is converted to the oxazoline (2), to protect the secondary hydroxyl group, and (2) is converted to the fluoride (3). The oxazoline protecting group is 55 removed by treatment with acid and the resulting amino-alcohol (4) converted to florfenicol I. However, the Schumacher et al. process again requires the use of expensive chiral starting materials. 2 EP0 674 618 B1 I Clark et al., in Synthesis, (1991) pp. 891-894, disclose a process for the synthesis of florfenicol via the stereose- lective hydrolysis of ethyl D,L-f/ireo-3-(4-methylthiophenyl)-serinate hydrochloride (5) using enzymes to give (2S,3R)- 3-(4-methyl-thiophenyl)serine (7) and the unreacted ester ethyl (2R,3S)-3-(4-methyl-thiophenyl)serinate hydrochloride (6). The acid (7), and the ester (6), are then converted via alternative multi-step sequences to the R,R-oxazoline (2). Compound (2) is then converted to florfenicol by the process of Schumacher et al., described above. EP0 674 618 B1 CH3 ^"y^l NH-fHCl (5) COzCjJ-ls OH 10 15 CH3 NH2«Ha COzCzHs CO2H 20 OH (7) 25 30 \ (2) " OH V ' 35 CH3-SO2 The Clark et al. process, while avoiding the use of expensive chiral starting materials, is chemically inefficient, 40 producing a mixture of chiral ester (6) and acid (7) which must be separately converted to (2). Thus, the prior art does not teach a chemically efficient stereoselective process for the synthesis of florfenicol that avoids the use of expensive chiral precursors. SUMMARY OF THE INVENTION 45 The present invention comprises a process for the asymmetric synthesis of florfenicol, thiamphenicol or chloram- phenicol comprising the steps: (c) regioselectively opening a chiral epoxide of the formula 50 55 4 EP0 674 618 B1 wherein R is nitro or methanesulfonyl, by sequentially treating with a strong base, a Lewis acid and dichloroace- tonitrile to form an oxazoline of the formula OH 10 is wherein R is as defined above; (d) stereoselective inversion/isomerization of the oxazoline of step (c) by sequentially treating with: (i) a lower alkylsulfonyl chloride and a tertiary amine base; (ii) aqueous acid; and (iii) an alkali metal hydroxide; to form an oxazoline of the formula 20 25 30 wherein R is as defined above; and (e) either: 35 (i) wherein R is methanesulfonyl, treating the oxazoline of step (d) with a fluorinating agent, then hydrolyzing the oxazoline with acid to obtain florfenicol; or (ii) hydrolyzing the oxazoline of step (d) with acid to obtain: 40 (a) wherein R is methanesulfonyl, thiamphenicol; or (b) wherein R is nitro, chloramphenicol. Preferably the chiral epoxide of step (c) is prepared from a trans cinnamic acid derivative of the formula H O 50 55 wherein R is nitro or methanesulfonyl, by: (a) converting the acid to an acid chloride using a chlorinating agent, and reducing the acid chloride to a trans allylic alcohol with a reducing agent; 5 EP0 674 618 B1 (b) asymmetrically epoxidizing the allylic alcohol of step (a), by reacting with t-butylhydroperoxide in the presence of a chiral epoxidation catalyst prepared from titanium (IV) isopropoxide and L-diisopropyltartaric acid, to form the chiral epoxide of the formula 5 10 wherein R is as defined above. is Preferred is a process as described above wherein the chlorinating agent of step (a) isthionyl chloride, the reducing agent of step (a) is NaBH4, the lower alkylsulfonyl chloride of step (d) is MsCI, the tertiary amine base of step (d) is triethylamine, the aqueous acid of step (d) is sulfuric acid, the alkali metal hydroxide of step (d) is NaOH, the fluorinating agent of step (e) is CF3CH(F) 20 CF2N(C2H5)2, and the acid of step (e) is AcOH. More preferred is a process as described above wherein the strong base of step (c) is an alkali metal hydride, preferably sodium hydride, and the Lewis acid of step (c) is zinc chloride. In an alternative embodiment, the process of the instant invention comprises the isomerization of the S,S-isomer 25 of florfenicol to the R,S-isomer (I) by sequentially treating with: (i) a lower alkylsulfonyl chloride and a tertiary amine base; (ii) an alkali metal hydroxide; (iii) aqueous acid. In a third embodiment the process of present invention comprises a process for regioselectively opening an epoxide of the formula 30 35 wherein R1 is methanesulfonyl, nitro or hydrogen by sequentially treating with a strong base, a Lewis acid and dichlo- roacetonitrile to form a f/ireo-oxazoline of the formula 40 OH OH 45 50 respectively, wherein R1 is as defined above. The epoxide opening process can be carried out on chiral (as shown) or racemic starting materials. Where chiral starting materials are used the reaction is both regio- and stereo-selective, producing chiral oxazolines. Preferred is a process for preparing an oxazoline as described above wherein the strong base is an alkali metal 55 hydride, preferably sodium hydride, and the Lewis acid is zinc chloride. The process of the present invention does not suffer the shortcomings of the prior art processes. It is chemically efficient, proceeds in high yield, and avoids the problems of expensive chiral starting materials by utilizing a reusable chiral auxiliary to introduce optical activity. 6 EP0 674 618 B1 DETAILED DESCRIPTION As used herein: 5 "fluorinating agent" is a reagent or combination of reagents capable of converting a primary alcohol to the analogous fluoride. Preferred fluorinating agents include: a,a-difluoroalkylamine fluorinating agents disclosed in U.S. Patent No. 4,876,352, such as N-(1 ,1 ,2,3,3, 3-hexafluoropropyl)diethylamine; HF; phosphorous fluorides; 2-chloro- 1 ,1 ,2-trifluorotriethylamine; and inorganic fluoride, such as LiF, in a polyol solvent. Most preferred is N- (1 ,1 ,2,3,3,3-hexafluoropropyl)-diethylamine. 10 "lower alkyl" means a saturated hydrocarbon chain having from 1-6 carbon atoms, the chain being straight or branched; "alkali metal hydroxide" means sodium, lithium or potassium hydroxide, preferably NaOH; "strong base" means a strong nonaqueous base selected from the group consisting of alkali metal hydride, alkali metal alkoxide and lower alkyllithium; is "alkali metal hydride" means sodium, lithium or potassium hydride, preferably sodium hydride; "alkali metal alkoxide" means an alkali metal salt of a lower alkyl alcohol.
Load more

Recommended publications
  • An Integrated Flow and Batch-Based Approach for the Synthesis of O-Methyl Siphonazole Amarcus Combined Flow and Batch Synthesis of O-Methyl Siphonazole Baumann, Ian R
    LETTER 1375 An Integrated Flow and Batch-Based Approach for the Synthesis of O-Methyl Siphonazole AMarcus Combined Flow and Batch Synthesis of O-Methyl Siphonazole Baumann, Ian R. Baxendale, Malte Brasholz, John J. Hayward, Steven V. Ley, Nikzad Nikbin Innovative Technology Centre, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK E-mail: [email protected] Received 21 February 2011 has transformed flow chemistry from an academic interest Abstract: The bisoxazole containing natural product O-methyl si- phonazole was assembled using a suite of microreactors via a flow- to a valuable enabling technology that overcomes several based approach in concert with traditional batch methods. The use of the bottlenecks traditionally faced by synthetic chem- 6 of a toolbox of solid-supported scavengers and reagents to aid puri- ists. As such the generation and immediate use of hazard- fication afforded the natural product in a total of nine steps. ous, toxic, or unstable intermediates7 has been reported as Key words: oxazoles, Claisen condensation, flow chemistry, well as the possibility to more reliably perform reaction microreactors, solid-supported reagents scale-up.8 Furthermore, flow reactors can be transformed into automated platforms by the addition of liquid han- dling and fraction collector modules expanding the work- As part of our ongoing interest in oxazole-containing nat- ing capabilities of the units and allowing for 24/7 working 9 ural products,1 we have devised a synthetic route to the regimes. Finally, individual reactions can be telescoped bisoxazole alkaloid O-methyl siphonazole (2), which was into one continuous flow sequence, thus avoiding the iter- discovered by König and co-workers in 2006, along with ative isolation, purification, and reprocessing of interme- 10 the C-21-demethylated parent compound siphonazole (1, diates.
    [Show full text]
  • 5 Phosphorus Oxychloride1 Acute Exposure Guideline Levels
    Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 Committee on Acute Exposure Guideline Levels Committee on Toxicology Board on Environmental Studies and Toxicology Division on Earth and Life Studies Copyright © National Academy of Sciences. All rights reserved. Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 THE NATIONAL ACADEMIES PRESS 500 FIFTH STREET, NW WASHINGTON, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Insti- tute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by Contract No. W81K04-06-D-0023 and EP-W-09-007 be- tween the National Academy of Sciences and the U.S. Department of Defense and the U.S. Environmental Protection Agency. Any opinions, findings, conclusions, or recom- mendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13: 978-0-309-21987-7 International Standard Book Number-10: 0-309-21987-6 Additional copies of this report are available from The National Academies Press 500 Fifth Street, NW Box 285 Washington, DC 20055 800-624-6242 202-334-3313 (in the Washington metropolitan area) http://www.nap.edu Copyright 2011 by the National Academy of Sciences.
    [Show full text]
  • Recent Syntheses of Steroidal Oxazoles, Oxazolines and Oxazolidines
    A Platinum Open Access Journal Review for Organic Chemistry Free to Authors and Readers DOAJ Seal Arkivoc 2021, part i, 471-490 Recent syntheses of steroidal oxazoles, oxazolines and oxazolidines Besma Bendif,a,b Malika Ibrahim-Ouali,*a and Frédéric Dumur c aAix Marseille Univ, CNRS, Centrale Marseille, iSm2, F-13397 Marseille, France bLaboratoire de Chimie Appliquée, Faculté des Sciences, Université du 08 mai 1945 Guelma, Algeria cAix Marseille Univ, CNRS, ICR, UMR 72 73, F-13397 Marseille, France Email: [email protected] Received 03-15-2021 Accepted 04-11-2021 Published on line 05-08-2021 Abstract It was found that the introduction of heterocycles to steroids often leads in a change of their physiological activity and the appearance of new interesting biological precursors. Recent developments in the syntheses of steroidal oxazoles, oxazolines, and oxazolidines are described herein. The biological activities of those steroidal derivatives for which data are available are given. Keywords: Steroids, oxazoles, oxazolines, oxazolidines DOI: https://doi.org/10.24820/ark.5550190.p011.512 Page 471 ©AUTHOR(S) Arkivoc 2021, i, 471-490 Bendif, B. et al. Table of Contents 1. Introduction 2. Synthesis of Steroidal Oxazoles 3. Synthesis of Steroidal Oxazolines 4. Synthesis of Steroidal Oxazolidines 5. Conclusions Acknowledgements References 1. Introduction Steroids constitute an extensive and important class of biologically active polycyclic compounds that are widely used for therapeutic purposes.1-3 Even after decades of research, the total synthesis of steroid nuclei by improved strategies continues to receive considerable attention. Numerous methods have been exploited for the total synthesis of steroids which are widely distributed in nature and which possess practical medical importance.
    [Show full text]
  • Block-Poly(2-Methyl-2-Oxazoline)
    ENGINEERING OF POLY(2-OXAZOLINE)S FOR A POTENTIAL USE IN BIOMEDICAL APPLICATIONS by Camille Legros A thesis presented to the University of Waterloo, Université de Liege and Université de Bordeaux in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Chemical Engineering (Nanotechnology) Waterloo, Ontario, Canada, 2015 © Camille Legros 2015 'I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public.' ii iii Abstract Résumé: Ce travail décrit d'abord l’élaboration de nanogels hydrophiles stimulables, sensibles à un changement de pH et à un environnement où les propriétés d’oxydo-réduction peuvent varier. Ils ont été synthétisés en milieu dilué, d’une part, et en émulsion inverse, d’autre part; dans les deux cas à partir d’un copolymère statistique composé d’unités 2-éthyl-2-oxazoline et éthylène imine. Ces nanogels n’ont pas montré d’interactions spécifiques avec des protéines telles que la BSA et se sont avérés non-toxiques in vitro. Une plateforme à base d’un copolymère POx statistique porteur de fonctions aldéhydes a par ailleurs permis d’accéder à une librairie de POx, incluant des structures greffées et réticulées. Enfin, l’auto-assemblage en solution d’un copolymère à blocs de type poly(2-methyl-oxazoline)-b-poly(2-isopropyl-2-oxazoline) (PMeOx- b-PiPrOx), a été étudié en détail. Des micelles ont été observées à des temps courts au-dessus du point trouble du PiPrOx.
    [Show full text]
  • Novel Functional Poly(2-Oxazoline)S As Potential Carriers for Biomedical Applications
    Technische Universität München Department Chemie WACKER-Lehrstuhl für Makromolekulare Chemie Novel Functional Poly(2-oxazoline)s as Potential Carriers for Biomedical Applications Robert Luxenhofer Vollständiger Abdruck der von der Fakultät für Chemie der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. Kai-Olaf Hinrichsen Prüfer der Dissertation: 1. Priv.-Doz. Dr. Rainer Jordan 2. Univ.-Prof. Dr. Horst Kessler 3. Univ.-Prof. Dr. Andreas Türler Die Dissertation wurde am 29.05.2007 bei der Technischen Universität München ein- gereicht und durch das Department Chemie am 26.06.2007 angenommen. In Vivo Veritas! Die vorliegende Arbeit wurde am WACKER-Lehrstuhl für Makromolekulare Chemie (zuvor Lehrstuhl für Makromolekulare Stoffe) im Department Chemie der Technischen Universität München in der Zeit von März 2004 bis Mai 2007 unter der Leitung von Herrn PD Dr. Rainer Jordan angefertigt. Insbesondere möchte ich mich bei meinem Mentor und Betreuer PD Dr. Rainer ´Ray´ Jordan sehr herzlich bedanken, dass er mir die Möglichkeit gegeben hat, an diesem Projekt zu arbeiten. Ich glaube das war die interessanteste Doktorarbeit die ich hätte finden können, selbst wenn ich gesucht hätte. Ich war sehr froh über all die Freiheit die ich hatte, wobei man immer vorbeikommen konnte, wenn man ein Problem hatte. Außerdem bin ich dankbar für die Arbeits- und Konferenzaufenthalte in New York, Flic en Flac, Budapest, San Francisco etc., die ich genießen konnte und die große Geduld mit mir. Prof. Dr.-Ing. Oskar Nuyken und Prof. Dr. Bernhard Rieger danke ich für die Auf- nahme bzw. die Möglichkeit meines Verbleibs am Lehrstuhl.
    [Show full text]
  • And Enantioselective Synthesis of P-Hydroxy-A-Amino Acids by Condensation of Aldehydes and Ketones with Glycine
    4252 J. Am. Chem. SOC.1985, 107, 4252-4259 mL and DMF and saturated with methylamine gas at 0 OC. The vessel mL volume) joined to the solvent distillation apparatus, waste, and was sealed and agitated for 1 day. The polymer was washed successively vacuum pump via Teflon tubing. in dioxane, ethanol, 2 N NaOH/i-PrOH (l:l), water (until eluate neu- In summary, we have shown for the first time the possibility to per- tral), ethanol, and ether. After drying in vacuo, the polymer (3.7 g/3.8 form highly efficient condensation reactions, by transferring polymer- mequiv of amino groups/l g of dry weight) was suspended in a mixture bound electrophiles (Le., active esters) via a mediator (shadchan) to of water (1.5 mL), ethanol (0.5 mL), triethylamine (7 mL), and 4- polymer-bound nucleophiles (i.e., amines). We have also shown the chloropyridine hydrochloride (4.7 g) in a glass pressure vessel, sealed and possibility of on-line monitoring which is relevant for automation. heated for 4 days at 140 OC. The polymer was washed as before, and The mediator methodology developed here is believed not to be limited unreacted amino groups were blocked by acetylation (acetic anhydride to acylation and related processes but to be expandable to other chemical in CH2C12,then base wash). The washed DMAP polymer was dried at processes that involve the creation of activated intermediates. These 150 OC in vacuo until constant weight. Incorporation of pyridine groups possibilities are currently under investigation. was determined by potentiometric chloride titration of the hydrochloride salt bound to the polymer: 2.53 mequiv/g compared to 3.15 mequiv/g Acknowledgment.
    [Show full text]
  • Halogenation Reagents
    Halogenation Reagents Halogenation is a basic and fundamental transformation in organic chemistry, and halogenated compounds are of extreme importance as building blocks in organic synthesis. The development of modern coupling reactions, such as the [P2140] Suzuki-Miyaura and Mizoroki-Heck reactions, have greatly increased the demand for halogenated compounds as starting materials. P2140 (2.3 eq.) On the other hand, introduction of fluorine into a certain position of bioactive compound such as a pharmaceutical and an agricultural chemical may remarkably reduce the toxicity of the compound, or improve the efficiency of medicine. This is due to the structurally mimic and blocking effect characterized by fluorine. P2140 (3 eq.) In response to this situation, a number of novel halogenation reagents have been developed. 4-tert-Butyl-2,6-dimethylphenylsulfur trifluoride (FLUOLEAD™) [B3664] is introduced as below: B3664 is a novel nucleophilic 1-Fluoro-3,3-dimethyl-1,2-benziodoxole [F0957] is a hypervalent fluorinating agent which was first reported by Umemoto et al.1) iodine derivative developed by Stuart et al.3) F0957 is stable to air Differing from other existing fluorinating agents, such as DAST, and moisture and used as an electrophilic fluorinating reagent for B3664 is a crystalline solid with high thermal stability and less a α-monofluorination of β-ketoesters in the presence of fuming character, which makes it easier to handle. B3664 triethylamine trihydrofluoride. fluorinates a hydroxyl or carbonyl group to afford the corresponding fluorinated compounds in good yields.1) F I O [F0957] O O Ph OEt F0957(2eq.) F O O Et3N-3HF(2.7eq.) [B3664] Ph OEt CH2Cl2 O O 40oC,24h Ph OEt F F Dibromoisocyanuric acid (DBI) [D3753] which was first reported by Gottardi, is a mild and highly effective brominating agent,4a,b,c) and has superior brominating ability when compared with N-bromosuccinimide (NBS), which is frequently used in organic IF5-Pyridine-HF (Hara Reagent) [P2140] is also a novel synthesis.
    [Show full text]
  • Phosphonate–Phosphonochloridate Conversion Bogdan Iorga, Duncan Carmichael, Philippe Savignac
    Phosphonate–phosphonochloridate conversion Bogdan Iorga, Duncan Carmichael, Philippe Savignac To cite this version: Bogdan Iorga, Duncan Carmichael, Philippe Savignac. Phosphonate–phosphonochloridate conversion. Comptes rendus de l’Académie des sciences. Série IIc, Chimie, Elsevier, 2000, 3 (11-12), pp.821-829. 10.1016/s1387-1609(00)01207-x. hal-03161486 HAL Id: hal-03161486 https://hal.archives-ouvertes.fr/hal-03161486 Submitted on 10 Mar 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Phosphonate-Phosphonochloridate Conversion Bogdan Iorga, Duncan Carmichael, Philippe Savignac Laboratoire Hétéroéléments et Coordination, UMR CNRS 7653, DCPH, Ecole Polytechnique, 91128 Palaiseau Cedex, France; E-mail : [email protected] __________________________________________________________________________________________ Abstract - This review deals with the phosphonate-phosphonochloridate conversion. The different phosphorus-chlorine bond forming reagents (COCl2, (COCl)2, SOCl2, PCl5, POCl3, Ph3PCl2, trichloro(o-phenylenedioxy)phosphorane)
    [Show full text]
  • Recent Advances in the Synthesis of Oxazole-Based Molecules Via Van Leusen Oxazole Synthesis
    molecules Review Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis Xunan Zheng 1,2, Wei Liu 3,* and Dawei Zhang 1,* 1 College of Chemistry, Jilin University, Changchun 130012, China; [email protected] 2 College of Plant Science, Jilin University, Changchun 130062, China 3 Department of Pesticide Science, Plant Protection College, Shenyang Agricultural University, Shenyang 110866, China * Correspondence: [email protected] (W.L.); [email protected] (D.Z.); Tel.: +86-188-1775-2588 (W.L.); +86-431-8783-6471 (D.Z.) Academic Editors: Anna Carbone and Fabio Bertozzi Received: 2 March 2020; Accepted: 23 March 2020; Published: 31 March 2020 Abstract: Oxazole compounds, including one nitrogen atom and one oxygen atom in a five-membered heterocyclic ring, are present in various biological activities. Due to binding with a widespread spectrum of receptors and enzymes easily in biological systems through various non-covalent interactions, oxazole-based molecules are becoming a kind of significant heterocyclic nucleus, which have received attention from researchers globally, leading them to synthesize diverse oxazole derivatives. The van Leusen reaction, based on tosylmethylisocyanides (TosMICs), is one of the most appropriate strategies to prepare oxazole-based medicinal compounds. In this review, we summarize the recent advances of the synthesis of oxazole-containing molecules utilizing the van Leusen oxazole synthesis from 1972, aiming to look for potential oxazole-based medicinal compounds, which are valuable information for drug discovery and synthesis. Keywords: van Leusen; TosMICs; oxazole; synthesis 1. Introduction The oxazole ring, with one nitrogen atom and one oxygen atom, which are widely displayed in natural products and synthetic molecules, is known as a prime skeleton for drug discovery.
    [Show full text]
  • Synthetic Methods of Phosphonopeptides
    molecules Review Synthetic Methods of Phosphonopeptides Jiaxi Xu State Key Laboratory of Chemical Resource Engineering, Department of Organic Chemistry, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, China; [email protected]; Tel./Fax: +86-10-6443-5565 Academic Editors: Graeme Barker and Simona Rapposelli Received: 8 November 2020; Accepted: 10 December 2020; Published: 12 December 2020 Abstract: Phosphonopeptides are phosphorus analogues of peptides and have been widely applied as enzyme inhibitors and antigens to induce catalytic antibodies. Phosphonopeptides generally contain one aminoalkylphosphonic acid residue and include phosphonopeptides with C-terminal aminoalkylphosphonic acids and phosphonopeptides with a phosphonamidate bond. The phosph- onamidate bond in the phosphonopeptides is generally formed via phosphonylation with phosphonochloridates, condensation with coupling reagents and enzymes, and phosphinylation followed by oxidation. Pseudo four-component condensation reaction of amides, aldehydes, alkyl dichlorophosphites, and amino/peptide esters is an alternative, convergent, and efficient strategy for synthesis of phosphonopeptides through simultaneous construction of aminoalkylphosphonic acids and formation of the phosphonamidate bond. This review focuses on the synthetic methods of phosphonopeptides containing a phosphonamidate bond. Keywords: phosphonamidate; phosphonopeptide; β-phosphonopeptide; γ-phosphonopeptide; peptide 1. Introduction Phosphonopeptides are phosphorus analogues
    [Show full text]
  • Download Author Version (PDF)
    Dalton Transactions Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/dalton Page 1 of 39 Dalton Transactions Chiral multidentate oxazoline ligands based on cyclophosphazene cores: Synthesis, characterization and complexation studies Dheeraj Kumar, Jatinder Singh and Anil J. Elias ,* ____________________________________________________________________ Chiral oxazoline based bi and hexadentate ligands built on cyclophosphazene cores have been synthesized and characterized. (NPPh 2)2[NP(m-OC 6H4C(O)OCH 3)2] (1) was prepared by the reaction of gem -(NPPh 2)2(NPCl 2) with methyl-3-hydroxy benzoate in presence of Cs 2CO 3. Compound 1 was converted to the dicarboxylic acid (NPPh 2)2[NP(m-OC 6H4C(O)OH)2] (2) Manuscript using base promoted hydrolysis with KO(t-Bu).
    [Show full text]
  • Phenyl Esters of Oxalic Acid. by Rogsradams and H
    2716 ROGER ADAMS AND H. GILMAN. constitution of the salts or of the alcohols. The salting out efficiency of a salt seems rather to be a function of its solubility in the water and in the alcohol, of the amount oi water with which it unites to form its lowest hydrate, and of the abilitv of the alcohol to replace the water of hydra- tioll. MINNEAPOLIS MINN iCONTRIBUTIOEa FROM THE CHEMICAL LABORATORYOF HARVARDUNIv&RSITY. 1 PHENYL ESTERS OF OXALIC ACID. BY ROGSRADAMS AND H. GU.HAN. Received August 12. 1915. Introduction. In the course of a research in this laboratory, we desired to use one of the substituted phenyl esters of oxalic acid. In reviewing the methods already available for the preparation of these substances, we found them to be few in number, limited in applicability and not suited to the prepara- tion of the particular compound wanted. Nencki' first prepared the phenyl ester of oxalic acid by boiling phosphorus oxychloride with an- hydrous oxalic acid and phenol. This method was extended by Bischoff2 to the preparation of substituted phenyl esters of oxalic acid, and was shown by him to work well with certain types of substituted phenols. With many phenyl derivatives, however, only small yields of esters could be thus produced, and in several cases the esters, if they were formed at all, could not be isolated from the reaction mixtures. Thus, e. g., the cresols, xylenols and carvacrol gave good results, thymol, p- and m-nitro- phenols gave very poor yields, while the desired products from the o-nitro- phenol, a- and &naphthols, could not be obtained.
    [Show full text]